Ligand Pharmaceuticals Inc. to Report Third Quarter Results on November 5th
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today plans to report third quarter 2012 financial results on Monday, November 5, 2012. Ligand’s President and CEO, John L. Higgins, Executive Vice President and COO, Matt Foehr and Vice President of Finance and CFO, John Sharp will host the conference call.